Sunday, November 28, 2021


Serum Institute, ICMR complete enrolment in phase-III trials for COVID-19 vaccine

SII and ICMR are conducting phase II/III clinical trial of the vaccine at 15 different centres across the country.

India records 45,903 new COVID-19 cases, 490 more deaths

The total number of people who have recuperated from the disease surged to 79,17,373, pushing the national recovery rate to 92.56 per cent.

Indians more resistant to Covid

Suggest two studies which have explored the factors behind low mortality rate in India

Horses hold key to Covid care?

Researchers explore possibility of utilising antiserum derived from the animals as a therapeutic in Covid treatment

BCG vaccine shields elderly from Covid: ICMR study

ICMR study suggests it induces innate, adaptive immunity among elderly individuals

Remdesivir gets FDA nod

Drug gets approval for use in adults, paediatric patients of 12 years and above and weighing more than 40 kg for Covid treatment

Drugs Controller General of India nod for Covaxin phase 3 trials

The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech. The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech’s BSL-3 (Bio-Safety Level 3)

India’s COVID-19 infection tally crosses 74 lakh with 62,212 new cases

"The active cases of coronavirus infection dropped below eight lakh for the first time in one-and-half months."

India’s COVID count reaches 67,57,132, spike of over 72 thousand cases

With 986 deaths, the toll due to the disease in the country now stands at 1,04,555.

India’s daily COVID-19 spike lowest since August

Out of the total cases, 9,19,023 are currently active, 56,62,490 have been discharged, while 1,03,569 lost the battle against the viral disease.

Latest News

- Advertisement -